Staphylococcus lugdunensis endophthalmitis following dexamethasone intravitreal implant

Indian J Ophthalmol. 2019 Mar;67(3):424-426. doi: 10.4103/ijo.IJO_720_18.

Abstract

We present a unique case of endophthalmitis with Staphylococcus lugdunensis following dexamethasone intravitreal implant for branch retinal vein occlusion associated with cystoid macular edema. Patient did not show favorable clinical response after vitrectomy and intravitreal antibiotics; so, we decided to repeat vitrectomy, remove the steroid implant and fill the eye with silicon oil, and repeat intravitreal vancomycin. Vision has improved from hand movements at presentation to counting fingers at 1.5 m after second vitrectomy and final visual acuity 3 months later after silicon oil removal was 6/36.

Keywords: Dexamethasone implant; Staphylococcus lugdunensis; endophthalmitis; silicon oil.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Dexamethasone / administration & dosage
  • Dexamethasone / adverse effects*
  • Drug Implants / adverse effects
  • Endophthalmitis / diagnosis
  • Endophthalmitis / etiology*
  • Endophthalmitis / microbiology
  • Eye Infections, Bacterial / diagnosis
  • Eye Infections, Bacterial / etiology*
  • Eye Infections, Bacterial / microbiology
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / adverse effects
  • Humans
  • Intravitreal Injections
  • Retinal Vein Occlusion / drug therapy
  • Slit Lamp Microscopy
  • Staphylococcal Infections / diagnosis
  • Staphylococcal Infections / etiology*
  • Staphylococcal Infections / microbiology
  • Staphylococcus lugdunensis / isolation & purification*
  • Tomography, Optical Coherence
  • Visual Acuity*

Substances

  • Drug Implants
  • Glucocorticoids
  • Dexamethasone